scPharmaceuticals Inc. Annual Interest Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
scPharmaceuticals Inc. quarterly/annual Interest Expense history and growth rate from 2016 to 2023.
  • scPharmaceuticals Inc. Interest Expense for the quarter ending June 30, 2024 was $2.13M, a 6.17% increase year-over-year.
  • scPharmaceuticals Inc. Interest Expense for the twelve months ending June 30, 2024 was $8.39M, a 33% increase year-over-year.
  • scPharmaceuticals Inc. annual Interest Expense for 2023 was $8.12M, a 146% increase from 2022.
  • scPharmaceuticals Inc. annual Interest Expense for 2022 was $3.3M, a 28.2% increase from 2021.
  • scPharmaceuticals Inc. annual Interest Expense for 2021 was $2.58M, a 0.46% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.12M +$4.82M +146% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $3.3M +$727K +28.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $2.58M -$12K -0.46% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $2.59M +$820K +46.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $1.77M +$335K +23.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 $1.43M +$635K +79.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 $797K -$5.72M -87.8% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 $6.51M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.